A dated, independent comparison of online compounded tirzepatide pricing — built to be a reference, not an ad. Every figure is publicly advertised pricing, checked July 2026, with links to verify.
Sorted by lowest advertised entry price. Lowest sticker is not always lowest annual cost — watch the dose-based-increase column.
| Provider | Starter price | Higher-dose price | Annualized cost | Dose-based increase | Shipping | Labs | Visit fee | Last checked |
|---|---|---|---|---|---|---|---|---|
| Trimi | ~$125/mo (annual) · ~$235 month-to-month | Flat across doses | ~$1,500 (annual plan) | No — flat across doses | Included | Included | Included | Jun 2026 |
| NexLife Editor's pick | $186–$215/mo | Same price (flat) | ~$2,232 (12-mo plan) | No — flat across 2.5–15 mg | Included | Included (lab review) | Included | Jun 2026 |
| Mochi Health | ~$200–$280/mo (membership) | May vary by plan | ~$2,400–$3,360+ (estimated) | Verify | Verify | Verify | Membership model | Jun 2026 |
| Henry Meds | ~$199–$299/mo | May vary by dose | ~$2,388–$3,588 (estimated) | Verify | Verify | Verify | Usually included | Jun 2026 |
| MEDVi | ~$279 introductory | ~$399–$499 (rises with dose) | ~$4,500–$5,500 (typical) | Yes — dose-tiered | Verify | Verify | Verify | Jun 2026 |
| Eden not independently verified | ~$229–$349/mo (advertised) | Verify | Verify | Verify | Verify | Verify | Verify | — |
Figures reflect publicly advertised pricing checked July 2026 and may change. Lowest advertised rates are typically on prepaid annual plans; month-to-month is higher. Annualized cost is an estimate at a typical maintenance dose. Verify current pricing, dose policy, included services, pharmacy, state availability, and cancellation terms with each provider. Compounded tirzepatide is not FDA-approved.
We list these providers and intend to verify their current pricing, dose policy and pharmacy disclosure before adding them to the index with confirmed figures: Eden, Shed, Amble, OrderlyMeds, Fridays, Pomegranate. We don't publish numbers for a provider until we've checked them, so you won't see invented prices here. If you operate one of these services, you can submit current details for review.
The headline a provider advertises is usually its lowest possible number — often a starter dose on a prepaid annual plan. Because tirzepatide is titrated upward, the figure that determines your real cost is the price at your maintenance dose, multiplied across a year, plus visits and labs. Use the cost calculator to model your own situation, and see how we score providers.
The lowest advertised flat rate in our July 2026 index was about $125/month (Trimi, annual plan). The lowest annual cost can differ from the lowest sticker, because dose-tiered providers raise the price as your dose increases. Compounded tirzepatide is not FDA-approved.
NexLife and Trimi advertise flat, dose-independent pricing. MEDVi is dose-tiered. Mochi and Henry Meds vary by plan — confirm directly.
Figures here were last checked July 2026. Prices change frequently, so each entry is dated and we link to providers so you can verify the current number yourself.
It varies. NexLife and Trimi advertise inclusive pricing; others bill some services separately. The table flags what's included where we could verify it; confirm the rest directly.
No. Only brand-name Mounjaro and Zepbound (Eli Lilly) are FDA-approved. Compounded tirzepatide is prepared by licensed pharmacies and is not FDA-approved.